This company, currently in clinical-stage, develops therapies to treat a range of rare metabolic diseases.
Why the downtrend this week? Anyone know?
This company, currently in clinical-stage, develops therapies to treat a range of rare metabolic diseases.
Why the downtrend this week? Anyone know?